Key result
CRT is linked to a ~5% increase in AF frequency, predicted strongly by CRT non-response.
Why the study?
It was unknown whether CRT with biventricular pacing reduces the risk of AF development, and predictors of AF occurrence needed identification.
Does cardiac resynchronization therapy with biventricular pacing reduce the risk of atrial fibrillation in patients with systolic heart failure?
Cohort (n=126)
Does cardiac resynchronization therapy with biventricular pacing reduce the risk of atrial fibrillation in patients with systolic heart failure?
In patients with systolic heart failure receiving CRT, the frequency of AF increased over 24 months, with non-response to CRT, larger LA diameter, and posterolateral CS lead position identified as significant predictors of AF occurrence.
Answers are grounded in this paper and cite their sources.
AF frequency rose after CRT in this cohort; leaves open whether biventricular pacing affects arrhythmia risk in systolic HF.
Background and Objectives: Cardiac resynchronization therapy (CRT) is one of the effective therapeutic options in the treatment of systolic heart failure (HF) with persistent symptoms. This prospective study was designed to determine whether CRT with biventricular pacing would reduce the risk of development of atrial fibrillation (AF) and to identify predictors for AF occurrence. Materials and Methods: The study population consisted of 126 patients, with a mean age of 63.8 ± 9.1 years, who were eligible for CRT with biventricular pacing. Inclusion criteria were left ventricular ejection fraction (LVEF) ≤ 35%, QRS duration ≥ 130 msec, and persistent HF symptoms of New York Heart Association (NYHA) II or III, despite optimal drug therapy. Patients were followed for a period of 24 months and were evaluated through clinical, electrocardiographic, and echocardiographic examination at baseline (prior to CRT implantation), as well as at 6 and 24 months post-implantation. At the end of follow-up, patients were divided into clinical responders and non-responders based on the following criteria: decrease in NYHA class ≥ I, increase in LVEF ≥ 10%, and reduction in QRS duration ≥ 20 msec. Results: At follow-up, CRT was associated with a significant increase in LVEF (20.6 ± 6.9% pre-implantation, 32.9 ± 9.3% 24 months after implantation; p < 0.001), reduction in left ventricular end-diastolic and end-systolic diameters, and decrease in QRS duration (167.6 ± 14.3 msec pre-implantation, 131.7 ± 11.7 msec 24 months after implantation; p < 0.001), while left atrial (LA) diameter was slightly increased (p = 0.070). The frequency of AF occurrence increased after two years of follow-up (52.4% to 56.9%, p < 0.001). Significant predictors of AF occurrence in our study population were response to CRT—AF more frequent in non-responders (B = 8.134; p < 0.001), LA diameter—AF more frequent with larger LA diameter (B = 0.813; p < 0.001), and coronary sinus (CS) lead position—AF more frequent with posterolateral in comparison with lateral CS lead position (B = 5.159; p = 0.005). Conclusions: The results of our study provide new data on AF predictors in patients with HF subjected to CRT. There remains a permanent need for new predictors, which might help in patient selection and improvement in response rate.
No takes yet. Share an insight, caveat, or question.
Grbović et al. (2023) conducted a cohort in Systolic heart failure (n=126). Cardiac resynchronization therapy (CRT) with biventricular pacing vs. Baseline was evaluated on Frequency of atrial fibrillation (AF) occurrence (p=<0.001). Cardiac resynchronization therapy was associated with an increase in atrial fibrillation frequency from 52.4% to 56.9% at 2 years, with non-response to CRT as a strong predictor.
Synapse has enriched 10 related papers. Consider them for comparative context: